ShareValue scores for 600161.SHG: Valuation 61, Quality 53, Growth 40, Health 56.

600161.SHG
SSE

Beijing Tiantan Biological Products Corp Ltd

CN¥12.49(+1.96%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
61
Fair Value
Price vs Value
Quality
53
Moderate
Business Strength
Growth
40
Weak
Revenue & Earnings
Health
56
Moderate
Financial Stability
Momentum
21
Bearish
Price Trend

Company Details

About

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally. Its products include human serum albumin; intravenous human immunoglobulin; rabies immunoglobulin; tetanus immunoglobulin; hepatitis B immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex concentrate; lyophilized intravenous hepatitis B immunoglobulin; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026